Alkermes PLC (NAS:ALKS)
$ 29.65 0.15 (0.51%) Market Cap: 4.80 Bil Enterprise Value: 4.25 Bil PE Ratio: 15.21 PB Ratio: 3.71 GF Score: 69/100

Alkermes Plc at Bank of America Biotech SMID Cap Conference Transcript

Dec 07, 2022 / 01:00PM GMT
Release Date Price: $23.49 (+1.08%)
Operator

(Operator Instructions) At this time, it is my pleasure to turn the program over to your host, Dan Lundquist.

Daniel Lundquist

Good morning, everybody. I'm Dan Lundquist, BofA's health care specialist, and I'm pleased to be kicking off the inaugural biotech conference today. I'm standing in for Jason Gerberry, who cannot be here this morning. It's my pleasure to introduce Richard Pops, the CEO of Alkermes as our first speaker today. For the audience, feel free to use the chat box to submit any potential questions you may have.

With that, I'll hand it over to Richard for any introductory remarks, and then we'll jump right into Q&A. Richard?

Richard F. Pops
Alkermes plc - Chairman & CEO

Morning, Dan, good to see you. And good morning, everybody. I'm glad to kick this off for you all.

So I guess I'll just say a couple of things. If you haven't been paying attention to what's happening in Alkermes, you probably should start. It's an exciting time for the company because the maturation of a couple of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot